Objective: To determine the roles of the eicosanoids thromboxane and prostacyclin, and their compartmentalization, in the regulation of placental blood flow.
Methods: First, the sites of production of thromboxane and prostacyclin were determined within the placental villus using immunohistochemical staining for thromboxane and prostacyclin synthetase. Second, the production of both eicosanoids was studied in cultured trophoblasts and compared with that in the villous core by measuring the metabolites thromboxane B2 and 6-keto-prostaglandin F1α. Finally, eicosanoid production was assessed in intact villi after stimulation by an acute change in oxygen content, 5% to 95%.
Results: Immunohistochemical staining showed that thromboxane production was primarily within the trophoblasts, whereas prostacyclin production was localized to the endothelial cells within the villi. In culture, we found preferential production of prostacyclin by the villous core cells and increased production of thromboxane by trophoblasts. Perifusion of intact villi demonstrated increased production of thromboxane by trophoblasts in response to an increase in oxygen content. Prostacyclin levels were too low to be detected.
Conclusions: Placental blood flow appears to be regulated by compartmentalized eicosanoids, with thromboxane affecting primarily the maternal side of the placental circulation and prostacyclin affecting primarily the fetal side.
1. Reilly FD, Russell PT. Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec1977;188:277-286.
2.
2. Myatt L.Current topic: Control of vascular resistance in the human placenta. Placenta1992;13:329-341.
3.
3. Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LO. Clinical implications of prostaglandin and thromboxane A2 formation, part 2. N Engl J Med1988;319:761-767.
4.
4. Nelson DM, Walsh SW. Thromboxane and prostacyclin production by different compartments of the human placental villus. J Clin Endocrinol Metab1989;68:676-683.
5.
5. Hedberg A, Mento PF, Liu ECK, Hollander AM, Wilkes BM. Evidence for functional thromboxane A2-prostaglandin H2 receptors in human placenta. Am J Physiol1989;256:E256-E263.
6.
6. Hirata M, Hayashi Y, Ushilubi F, et al. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature1991;349:617-619.
8. Kay HH, Hawkins SR, Wang Y, et al. Phosphorus 31 magnetic resonance spectroscopy of perifused human placental villi under varying oxygen concentrations. Am J Obstet Gynecol1993;168:246-252.
9.
9. Challis JRG, Vaughan M.Steroid synthetic and prostaglandin metabolizing activity is present in different cell populations from human fetal membranes and decidua. Am J Obstet Gynecol1987;157:1474-1481.
10.
10. Duchesne MJ, Thaler-Dao H, de Paulet AC. Prostaglandin synthesis in human placenta and fetal membranes. Prostaglandins1978;15:19-42.
11.
11. Maigaard S, Forman A, Andersson KE. Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit. Acta Physiol Scand1985;128:33-40.
12.
12. Maigaard S, Forman A, Andersson KE. Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit. Acta Physiol Scand1986;128:23-31.
13.
13. Mak KK, Gude NM, Salters WA, Boura AL. Effects of vasoactive autocoids on the human umbilical-fetal placental vasculature. Br J Obstet Gynaecol1984;91:99-106.
14.
14. Nelson DM, Walsh SW. Aspirin differentially affects thromboxane and prostacyclin production by trophoblast and villous core compartments of human placental villi. Am J Obstet Gynecol1989;161:1593-1598.
15.
15. Diss EM, Gabbe SG, Moore JW, Kniss DA. Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. Am J Obstet Gynecol1992;167:1046-1052.
16.
16. Ekblad U, Erkkola R, Uotila P.The effect of acute hypoxia on prostaglandin release in perfused human fetal placenta. Prostaglandins1987;33:553-560.
17.
17. Setty BNY, Walenga RW, Stuart MJ. Kinetic analyses of the effects of hyperoxia and hypoxia on vascular cyclooxygenase activity in vitro. Biochem Biophys Res Commun1984;125:170-176.
18.
18. Templeton AGB, McGrath JC, Whittle MJ. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery. Br J Pharmacol1991;103:1079-1084.
19.
19. Omar HA, Figueroa R, Omar RA, Tejani N, Wohn MS. Hydrogen peroxide and reoxygenation cause prostaglandin-mediated contraction of human placental arteries and veins. Am J Obstet Gynecol1992;167:201-207.
21. Svane D, Skajaa K, Andersson KE, Forman A.Effects of the thromboxane-receptor antagonists AH23848 and BM 13.177 on human uteroplacental arteries. Obstet Gynecol1992;80:234-240.
22.
22. Le SQ, Wasserstrum N, Monbouli JV, Vanhoutte PM. Contractile effect of endothelin in human placental veins: Role of endothelium prostaglandins and thromboxane. Am J Obstet Gynecol1993;169:919-924.
